2_uneSeuleSante
π Health and biotech
How science is preparing for antibiotic resistance

Antibiotic resistance : thinking about humans in the environment

with Agnès Vernet, Science journalist
On March 16th, 2022 |
3min reading time
Léonie Varobieff 1
Léonie Varobieff
PhD candidate in philosophy at ANSES and CNRS
Key takeaways
  • Antibiotic resistance raises questions about our relationship with health care, our perceptions of disease, and the position of humans within the community of living beings.
  • When the production of penicillin was industrialised in the 1940s, the use of antibiotics became widespread.
  • However, scientists have known since the discovery of antibiotics that unreasonable use and misuse ultimately threaten their effectiveness.
  • The WHO is now warning of the risk of a post-antibiotic era in which doctors would lack effective molecules.

It may seem sur­pri­sing that phi­lo­so­phy is inter­es­ted in anti­bio­tic resis­tance. Howe­ver, this public health pro­blem ques­tions our rela­tion­ship with heal­th­care, our repre­sen­ta­tions of disease, and the posi­tion of humans within the com­mu­ni­ty of living beings. Mira­cu­lous in terms of effec­ti­ve­ness, we must never­the­less start by recal­ling that anti­bio­tics are only one the­ra­peu­tic option among others. Although less spec­ta­cu­lar, these other options should not be overlooked.

A political history

In Europe and North Ame­ri­ca, approaches such as sani­ti­sing oint­ments or phages were aban­do­ned. The lat­ter, which uses dead­ly viruses against tar­ge­ted bac­te­ria, was a par­ti­cu­lar­ly deve­lo­ped tech­nique in the Soviet world. Its com­plex pres­crip­tion and par­ti­cu­lar logis­tics do not in them­selves explain why it was aban­do­ned in favour of anti­bio­tics. The poli­ti­cal context at the time and the Cold War must also be considered.

The spe­ci­fi­ci­ties of our Wes­tern culture com­bi­ned with the eco­no­mic inter­ests of the time favou­red the deve­lop­ment of anti­bio­tics. When peni­cil­lin pro­duc­tion was indus­tria­li­sed in the 1940s1, modern medi­cine was hap­py to be able to offer a stan­dar­di­sed pro­duct that could cure an infec­tion within days. The inci­dence of infec­tion-rela­ted deaths fell and anti­bio­tic use became widespread.

Indus­tria­li­sed coun­tries have mas­si­ve­ly expor­ted this stan­dar­di­sed the­ra­py to low-income coun­tries to treat infec­tious diseases. Very qui­ck­ly, howe­ver, coun­ter­feit or under-dosed drugs appea­red on the mar­ket, contri­bu­ting to the emer­gence of resistance.

Loo­king beyond eco­no­mic pro­fit, it is our way of unders­tan­ding bac­te­ria and our vul­ne­ra­bi­li­ties that anti­bio­tic resis­tance calls into ques­tion. Scien­tists have known since the dis­co­ve­ry of anti­bio­tics that their unrea­so­nable use and misuse ulti­ma­te­ly threa­ten their effec­ti­ve­ness. Howe­ver, they have been, and some­times still are, admi­nis­te­red pre­ven­ti­ve­ly to avoid secon­da­ry infec­tion, even in patients without risk fac­tors, or mas­si­ve­ly in live­stock until the ear­ly 2000s in Europe2.

Human and vete­ri­na­ry medi­cine has long prac­ti­sed, without taking into account its envi­ron­ment, even its imme­diate envi­ron­ment, neglec­ting the equi­li­brium of the micro-orga­nisms (patho­ge­nic or not) with which we coha­bit. The phi­lo­so­pher of bio­lo­gy Tho­mas Pra­deu ques­tions these boun­da­ries bet­ween ‘self’ and ‘non-self’3. Are these terms appro­priate when the pre­sence of these microbes is essen­tial for our survival ?

Never­the­less, the voca­bu­la­ry in the field is violent, using a war­like lexi­cal that evokes infec­tious agents. Medi­cine and hygie­nism ‘fight-against’ rather than ‘deal-with’ bac­te­ria, so advo­ca­ting their era­di­ca­tion in the col­lec­tive conscious­ness. These repre­sen­ta­tions hin­der our curio­si­ty about living things and our pro­pen­si­ty to seek balan­ced rela­tion­ships in biodiversity.

Facing the crisis

WHO warns of the risk of a post-anti­bio­tic era, in which doc­tors would lack effec­tive mole­cules. The cri­sis is serious, even though it was fore­seeable, even anti­ci­pa­ted. « Why have we been blind to it » is the first ques­tion that need to be ans­we­red when consi­de­ring the phenomenon.

This cog­ni­tive dis­so­cia­tion is not unre­la­ted to our mecha­nis­tic concep­tion inhe­ri­ted from Car­te­sian phi­lo­so­phy. When René Des­cartes depic­ted huma­ni­ty as being radi­cal­ly sepa­ra­ted from the rest of the living world in the ear­ly 17th cen­tu­ry, he esta­bli­shed that the pur­pose of acqui­ring know­ledge is to mas­ter nature, pre­ci­se­ly for the sake of human health, « which is undoub­ted­ly the first good and the foun­da­tion of all the other goods of this life« 4.

Although this thin­king has been constant­ly chal­len­ged by research in eco­lo­gy and bio­lo­gy, it remains cen­tral to when it comes to trai­ning doc­tors and vete­ri­na­rians. Without belit­tling it, it does, never­the­less, favour a type of care orien­ted towards “tech­nique” rather than “rela­tion­ship”.

The social sciences have shown, howe­ver, that depen­ding on whe­ther a per­son’s beliefs are orien­ted towards science, conspi­ra­cy theo­ries or scep­ti­cism, his or her beha­viour in rela­tion to anti­bio­tic pres­crip­tions will change.

Anti­bio­tic resis­tance thus raises ethi­cal ques­tions, and prac­ti­tio­ners will have rethink their role as care­gi­vers beyond their tech­ni­cal role as “hea­lers”. It also calls into ques­tion the cur­rent­ly unba­lan­ced doc­tor-patient rela­tion­ship and encou­rages co-construc­tion of care, even in the choice of pres­crip­tions5.

A carer is not a carer if he does not feel cared for by the per­son being cared for, as the psy­chia­trist Jean Oury ele­gant­ly put it. Thus, when we expect doc­tors or vete­ri­na­rians to ‘edu­cate’ their patients or clients so that they do not undu­ly demand anti­bio­tics or use them bet­ter, we misun­ders­tand what is at stake.

Rebuil­ding our rela­tion­ship with care would the­re­fore undoub­ted­ly open the way to more pro­found and las­ting changes in beha­viour than mana­ge­ment approaches are capable of doing. Approaches that are cur­rent­ly being adop­ted both by ins­ti­tu­tions and by many experts are the best way to respond to the anti­bio­tic-resis­tance health situa­tion. More inclu­sive approaches, such as « One Health« 6 are among the most inter­es­ting socie­tal approaches to invest in, pro­vi­ded that they go beyond mere win­dow-dres­sing to build a real col­lec­tive phi­lo­so­phi­cal investment.

1André Fro­ge­rais, Les ori­gines de la fabri­ca­tion des anti­bio­tiques en France, 2015. ⟨hal-01100810v4⟩)
2Les anti­bio­tiques uti­li­sés comme fac­teur de crois­sance n’ont été inter­dits en Europe qu’à par­tir de 2006.
3Edgar­do D. Caro­sel­la, Tho­mas Pra­deu, L’I­den­ti­té, la part de l’autre Immu­no­lo­gie et phi­lo­so­phie, Odile Jacob Ed., Sciences Coll., Paris, 2010.
4René Des­cartes, Dis­cours de la méthode, (1637), Gal­li­mard Flam­ma­rion, Coll. Phi­lo­so­phie, Paris, 2016.
5Pas­cale Moli­nier, Patri­cia Paper­man, San­dra Lau­gier, Sous la dir. Qu’est-ce que le Care ? Sou­ci des autres, sen­si­bi­li­té, res­pon­sa­bi­li­té, Payot Essais, Paris, 2021.
6https://​www​.poly​tech​nique​-insights​.com/​d​o​s​s​i​e​r​s​/​s​o​c​i​e​t​e​/​a​l​i​m​e​n​t​a​t​i​o​n​-​m​a​l​a​d​i​e​s​-​b​i​o​d​i​v​e​r​s​i​t​e​-​n​o​t​r​e​-​r​a​p​p​o​r​t​-​a​u​x​-​a​n​i​m​a​u​x​-​d​o​i​t​-​i​l​-​e​v​o​l​u​e​r​/​l​e​s​-​z​o​o​n​o​s​e​s​-​m​a​l​a​d​i​e​s​-​p​a​s​s​a​n​t​-​d​e​-​l​a​n​i​m​a​l​-​a​-​l​h​o​m​m​e​-​o​n​t​-​t​r​i​p​l​e​-​d​e​p​u​i​s​-​u​n​-​s​i​ecle/

Support accurate information rooted in the scientific method.

Donate